Evaluation of the compounding formula of compounding medicines by community pharmacies with Special Authorization for dosage individualization
DOI:
https://doi.org/10.3395/2317-269x.00572Keywords:
Community Pharmacy, Special Authorization, Pharmaceutical Compounding, Nova FriburgoAbstract
The main purpose of compounding medicines is to meet individual needs, such as therapeutic dose, appropriate dosage forms, and absence of pharmaceutical ingredients for patients with a history of intolerance, among other technical reasons. This work analyzes, through documentary research, the compounding formula for dosage individualization of oral capsules/mono drug containing an Active Pharmaceutical Ingredient (API), according to Order No. 344/98, and prepared by community pharmacies located in Nova Friburgo, Rio de Janeiro. Data were recorded in November 2006, from prescription books of pharmacies with Special Authorization issued by ANVISA (Brazilian National Health Surveillance Agency). From the 12253 analyzed formulae, 22% met the inclusion criteria of this study. The results lead us to the conclusion that the prevalence of compounded medication for dosage individualization was low. On average, only 34% of the formulae presented a different dosage from the standard one in the available specialties on the Brazilian pharmaceutical market, which results in a diminution of personalized, compounded medications. This study therefore highlights the need of a more substantial risk assessment to justify the compounding of real compounded prescriptions.Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Health Surveillance under Debate: Society, Science & Technology (Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnología) – “Visa em Debate”
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.
